Type I interferon rapidly restricts infectious hepatitis C virus particle genesis

Interferon-alpha (IFNα) has been used to treat chronic hepatitis C virus (HCV) infection for over 20 years with varying efficacy, depending on the infecting viral genotype. The mechanism of action of IFNα is not fully understood, but is thought to target multiple stages of the HCV lifecycle, inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Meredith, Luke W, Farquhar, Michelle J, Tarr, Alexander W, McKeating, Jane A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Viral Hepatitis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265257/
https://www.ncbi.nlm.nih.gov/pubmed/25066844
http://dx.doi.org/10.1002/hep.27333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265257/
https://www.ncbi.nlm.nih.gov/pubmed/25066844
http://dx.doi.org/10.1002/hep.27333

Ejemplares similares